Aspen Neuroscience
(Incorporated in Delaware) Aspen Neuroscience, Inc. is a leading clinical-stage regenerative medicine biotechnology company focused on developing autologous induced-pluripotent stem cell (iPSC)-derived therapies to address neurodegenerative diseases with high unmet medical need. Our lead product candidate, sasineprocel, is an investigational single-dose and autologous iPSC-based cell therapy being evaluated for the treatment of Parkinson’s disease (PD). […]
October 9, 2026 Read More